Erythropoietin pretreatment suppresses inflammation by activating the PI3K/Akt signaling pathway in myocardial ischemia-reperfusion injury

Rong,Ren; Xijun,Xiao

doi:10.3892/etm.2015.2534

Erythropoietin pretreatment suppresses inflammation by activating the PI3K/Akt signaling pathway in myocardial ischemia-reperfusion injury

Authors:
- Ren Rong
- Xiao Xijun
View Affiliations

Affiliations: Department of Cardiac Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P.R. China
Published online on: May 29, 2015 https://doi.org/10.3892/etm.2015.2534
Pages: 413-418
Copyright: © Rong et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Erythropoietin (EPO), a glycoprotein originally known for its important role in the stimulation of erythropoiesis, has recently been shown to have significant protective effects in animal models of kidney and intestinal ischemia‑reperfusion injury (IRI). However, the mechanism underlying these protective effects remains unclear. The aim of the current study was to evaluate the effects of EPO on myocardial IRI and to investigate the mechanism underlying these effects. A total of 18 male Sprague Dawley rats were randomly divided into three groups, namely the sham, IRI‑saline and IRI‑EPO groups. Rats in the IRI‑EPO group were administered 5,000 U/kg EPO intraperitoneally 24 h prior to the induction of IRI. IRI was induced by ligating the left descending coronary artery for 30 min, followed by reperfusion for 3 h. Pathological changes in the myocardial tissue were observed and scored. The levels of the proinflammatory cytokines, interleukin (IL)‑6, IL‑1β and tumor necrosis factor (TNF)‑α, were evaluated in the serum and myocardial tissue. Furthermore, the effects of EPO on phosphoinositide 3‑kinase/protein kinase B (PI3K/Akt) signaling and EPO receptor (EPOR) phosphorylation were measured. Pathological changes in the myocardial tissue, increased expression levels of TNF‑α, IL‑6 and IL‑1β in the myocardium, and increased serum levels of these mediators, as a result of IRI, were significantly decreased by EPO pretreatment. The effects of EPO were found to be associated with the activation of PI3K/Akt signaling, which suppressed the inflammatory responses, following the initiation of EPOR activation by EPO. Therefore, EPO pretreatment was demonstrated to decrease myocardial IRI, which was associated with activation of EPOR, subsequently increasing PI3K/Akt signaling to inhibit the production and release of inflammatory mediators. Thus, the results of the present study indicated that EPO may be useful for preventing myocardial IRI.

View Figures

View References

1	Chen K, Li G, Geng F, et al: Berberine reduces ischemia/reperfusion-induced myocardial apoptosis via activating AMPK and PI3K-Akt signaling in diabetic rats. Apoptosis. 19:946–957. 2014. View Article : Google Scholar : PubMed/NCBI
2	Yan X, Qiu W, Jia B, et al: Myocardial protection by interferon-γ late preconditioning during cardiopulmonary bypass-associated myocardial ischemia-reperfusion in pigs. Oncol Rep. 30:2145–2152. 2013.PubMed/NCBI
3	Lassaletta AD, Elmadhun NY, Zanetti AV, et al: Rapamycin treatment of healthy pigs subjected to acute myocardial ischemia-reperfusion injury attenuates cardiac functions and increases myocardial necrosis. Ann Thorac Surg. 97:901–907. 2014. View Article : Google Scholar : PubMed/NCBI
4	Du X, Hu X and Wei J: Anti-inflammatory effect of exendin-4 postconditioning during myocardial ischemia and reperfusion. Mol Biol Rep. 41:3853–3857. 2014. View Article : Google Scholar : PubMed/NCBI
5	Kim HJ, Joe Y, Kong JS, et al: Carbon monoxide protects against hepatic ischemia/reperfusion injury via ROS-dependent Akt signaling and inhibition of glycogen synthase kinase 3beta. Oxid Med Cell Longev. 2013:3064212013. View Article : Google Scholar : PubMed/NCBI
6	Hofmann BT and Jücker M: Activation of PI3K/Akt signaling by n-terminal SH2 domain mutants of the p85α regulatory subunit of PI3K is enhanced by deletion of its c-terminal SH2 domain. Cell Signal. 24:1950–1954. 2012. View Article : Google Scholar : PubMed/NCBI
7	Chen L, Wei X, Hou Y, Liu X, et al: Tetramethylpyrazine analogue CXC195 protects against cerebral ischemia/reperfusion-induced apoptosis through PI3K/Akt/GSK3β pathway in rats. Neurochem Int. 66:27–32. 2014. View Article : Google Scholar : PubMed/NCBI
8	Palis J: Primitive and definitive erythropoiesis in mammals. Front Physiol. 5:32014. View Article : Google Scholar : PubMed/NCBI
9	Jelkmann W: Physiology and pharmacology of erythropoietin. Transfus Med Hemother. 40:302–309. 2013. View Article : Google Scholar : PubMed/NCBI
10	Yang C, Zhao T, Lin M, et al: Helix B surface peptide administered after insult of ischemia reperfusion improved renal function, structure and apoptosis through beta common receptor/erythropoietin receptor and PI3K/Akt pathway in a murine model. Exp Biol Med (Maywood). 238:111–119. 2013. View Article : Google Scholar : PubMed/NCBI
11	Zhang Q, Bian H, Li Y, Guo L, Tang Y and Zhu H: Preconditioning with the traditional Chinese medicine Huang-Lian-Jie-Du-Tang initiates HIF-1α-dependent neuroprotection against cerebral ischemia in rats. J Ethnopharmacol. 154:443–452. 2014. View Article : Google Scholar : PubMed/NCBI
12	Liu X, Xie W, Liu P, et al: Mechanism of the cardioprotection of rhEPO pretreatment on suppressing the inflammatory response in ischemia-reperfusion. Life Sci. 78:2255–2264. 2006. View Article : Google Scholar : PubMed/NCBI
13	Meij JT, Sheikh F, Jimenez SK, et al: Exacerbation of myocardial injury in transgenic mice overexpressing FGF-2 is T cell dependent. Am J Physiol Heart Circ Physiol. 282:H547–H555. 2002. View Article : Google Scholar : PubMed/NCBI
14	Zhang S, Lv JW, Yang P, et al: Loss of dicer exacerbates cyclophosphamide-induced bladder overactivity by enhancing purinergic signaling. Am J Pathol. 181:937–946. 2012. View Article : Google Scholar : PubMed/NCBI
15	Liu H, Guo X, Chu Y and Lu S: Heart protective effects and mechanism of quercetin preconditioning on anti-myocardial ischemia reperfusion (IR) injuries in rats. Genes. 545:149–155. 2014.
16	Jia Y, Mo SJ, Feng QQ, et al: EPO-Dependent activation of PI3K/AKT/FOXO3a signalling mediates neuroprotection in in vitro and in vivo models of Parkinson's disease. J Mol Neurosci. 53:117–124. 2014. View Article : Google Scholar : PubMed/NCBI
17	Jun JH, Jun NH, Shim JK, Shin EJ and Kwak YL: Erythropoietin protects myocardium against ischemia-reperfusion injury under moderate hyperglycemia. Eur J Pharmacol. 745:1–9. 2014. View Article : Google Scholar : PubMed/NCBI
18	Lu MJ, Chen YS, Huang HS and Ma MC: Erythropoietin alleviates post-ischemic injury of rat hearts by attenuating nitrosative stress. Life Sci. 90:776–784. 2012. View Article : Google Scholar : PubMed/NCBI
19	He W, Wang Z, Zhou Z, et al: Lipopolysaccharide enhances Wnt5a expression through toll-like receptor 4, myeloid differentiating factor 88, phosphatidylinositol 3-OH kinase/AKT and nuclear factor kappa B pathways in human dental pulp stem cells. J Endod. 40:69–75. 2014. View Article : Google Scholar : PubMed/NCBI
20	Zhang J, Yao Y, Xiao F, et al: Administration of dexamethasone protects mice against ichemia/reperfusion induced renal injury by suppressing PI3K/AKT signaling. Int J Clin Exp Pathol. 6:2366–2375. 2013.PubMed/NCBI
21	Wang J, Li L and Jiang H: c-Cbl inhbition: A novel therapeutic approach for attenuating myocardial ischemia and reperfusion injury. Int J Cardiol. 186:50–51. 2015. View Article : Google Scholar : PubMed/NCBI
22	Lin Y, Chen L, Li W and Fang J: Role of high-mobility group box-1 in myocardial ichemia/reperfusion injury and the effect of ethyl pyruvate. Exp Ther Med. 9:1537–1541. 2015.PubMed/NCBI
23	Yao HC, Yang LJ, Han QF, et al: Postconditioning with simvastatin decreases myocardial injury in rats following acute myocardial ischemia. Exp Ther Med. 9:1166–1170. 2015.PubMed/NCBI
24	Rafiee P, Shi Y, Su J, et al: Erythropoietin protects the infant heart against ischemia-reperfusion injury by triggering multiple signaling pathways. Basic Res Cardiol. 100:187–197. 2005. View Article : Google Scholar : PubMed/NCBI